Skye Bioscience Inc (SKYE)

[Closewatcher]

I get it, but there has to be a balance of promo, or else you end up having to raise at 15 cents instead of say 40 cents.

We need a better sales guy to raise money than Cosmas. I do hate doing comparisons when companies are targeting different areas, but Zynerba was able to raise $13 million in 2014 to jump start their trials, just going off pre-clinical work & research. And going after markets considerably smaller than Nemus, so you're talking about high-risk, lower reward, in 2014 when cannabinoid work was more taboo:

https://www.bizjournals.com/philadelphia/blog/health-care/2014/10/synthetic-medicinal-marijuana-develtherapies.html

Cannabinoids have stripped their name from being taboo, and typically fall into the line of "disruptor" now. The cash we initially tried to raise shouldve been in the US with reputable financers. Again, Cosmas failing. NB1111, and NB1222 is more than enough to support an investment, let alone NB2111, NB2222, and NB3111 where research has been steadily improving to provide value.

When the company was at a 9 million market cap, it was easy to say it should be valued at 35. A little harder when we are staring 4 in the face to say we deserve a 10-bagger.